T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Chubb
CB
$134B
| $4.61B | 0.58% |
23,436,219
-1,240,735
| -5% | -$256M |
|
27
Elevance Health
ELV
$85.4B
| $4.56B | 0.58% |
9,455,757
+699,906
| +8% | +$346M |
|
28
Johnson & Johnson
JNJ
$628B
| $4.37B | 0.55% |
24,622,795
+3,912,430
| +19% | +$697M |
|
29
Atlassian
TEAM
$38.7B
| $4.25B | 0.54% |
22,693,727
+1,803,544
| +9% | +$385M |
|
30
Southern Company
SO
$106B
| $4.23B | 0.53% |
59,348,519
+1,976,664
| +3% | +$145M |
|
|
FISV
31
Fiserv Inc
FISV
$27.1B
| $4.17B | 0.53% |
46,900,333
+3,333,116
| +8% | +$323M |
|
32
Cigna
CI
$72.4B
| $4.14B | 0.52% |
15,718,124
-1,849,668
| -11% | -$477M |
|
33
Advanced Micro Devices
AMD
$799B
| $4.1B | 0.52% |
53,555,616
+316,285
| +0.6% | +$29.6M |
|
|
SCHW
34
Charles Schwab
SCHW
$187B
| $4B | 0.51% |
63,298,460
-6,010,588
| -9% | -$415M |
|
35
Stryker
SYK
$132B
| $3.96B | 0.5% |
19,905,052
-256,171
| -1% | -$60.2M |
|
36
Rivian
RIVN
$23.1B
| $3.64B | 0.46% |
141,564,738
-21,231,474
| -13% | -$663M |
|
37
JPMorgan Chase
JPM
$969B
| $3.57B | 0.45% |
31,667,210
+5,978,393
| +23% | +$741M |
|
38
Humana
HUM
$45.8B
| $3.54B | 0.45% |
7,572,451
-1,217,739
| -14% | -$542M |
|
39
Chipotle Mexican Grill
CMG
$41.5B
| $3.54B | 0.45% |
135,340,700
-2,744,500
| -2% | -$76.5M |
|
40
Ross Stores
ROST
$79.9B
| $3.49B | 0.44% |
49,657,768
+994,578
| +2% | +$88.6M |
|
41
Wells Fargo
WFC
$267B
| $3.42B | 0.43% |
87,369,282
+16,552,773
| +23% | +$726M |
|
42
Yum! Brands
YUM
$40.5B
| $3.41B | 0.43% |
30,044,947
-3,608,707
| -11% | -$420M |
|
43
Synopsys
SNPS
$79B
| $3.36B | 0.42% |
11,053,415
-263,695
| -2% | -$79.5M |
|
44
Veeva Systems
VEEV
$38.1B
| $3.25B | 0.41% |
16,414,343
+2,056,275
| +14% | +$378M |
|
45
Texas Instruments
TXN
$256B
| $3.24B | 0.41% |
21,113,372
+6,363,962
| +43% | +$1.07B |
|
46
Sempra
SRE
$56.1B
| $3.24B | 0.41% |
43,148,986
-6,091,170
| -12% | -$489M |
|
47
Ingersoll Rand
IR
$32.7B
| $3.16B | 0.4% |
75,163,087
+6,357,468
| +9% | +$289M |
|
48
Fortinet
FTNT
$120B
| $3B | 0.38% |
52,995,764
-487,911
| -0.9% | -$29M |
|
49
Walmart Inc
WMT
$917B
| $2.91B | 0.37% |
71,758,113
+5,055,960
| +8% | +$233M |
|
|
50
Philip Morris
PM
$289B
| $2.85B | 0.36% |
28,909,466
+13,126,188
| +83% | +$1.34B |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.